Merck & Co (MRK)

$89.38 2.05 (2.24%)

19:00 EST MRK Stock Quote Delayed 30 Minutes

The Coronavirus Pill Makes Merck a Solid Buy

By Vandita Jadeja Jul 8, 2021

Merck is a great pharma play with its coronavirus pill and strong, consistent dividend payouts. MRK stock is a solid buy.

Motivation Really Matters When It Comes to Organon

Hold Merck for Its Solid Dividend and Covid-19 Treatment Prospects

7 Dividend Stocks Offering Juicy Yields and Short-Squeeze Potential

Volume:

Previous Close -

Market Cap 226.25B

PE Ratio 13.28

EPS 6.73

Volume (Avg. Vol.) 13.53M

Day's Range $88.86 - $91.37

52-Week Range $81.04 - $134.63

Dividend & Yield $3.08 (3.45%)

MRK Stock Predictions, Articles, and Merck & Co News

What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Jun 3, 2021

So what did the stock market do today? Investors turned to new meme stocks like XERS and watched the OGN stock spinoff launch.

Merck Spinoff Organon Will Do Well Over Time

By Mark R. Hake, CFA Jun 2, 2021

The Merck spinoff Organon will likely do quite well. OGN stock is likely to be worth $52.77, or 48% above the when-issued price right now.

7 Best Stocks To Buy To Hedge Against A Potential Downturn

By Tezcan Gecgil, InvestorPlace Contributor Jun 1, 2021

With solid fundamental metrics, these defensive stocks deserve your attention now

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel, InvestorPlace Contributor Apr 28, 2021

So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

3 Top Blue-Chip Healthcare Stocks With Healthy Dividends

By Bob Ciura, Sure Dividend Apr 26, 2021

Healthcare stocks have some excellent dividend stocks among their ranks, and these three names are among the most reliable to buy.

7 Healthcare Stocks for a Reopening World

By Tezcan Gecgil, InvestorPlace Contributor Apr 26, 2021

The stock market is at all-time highs, and the world is starting to reopen. But these healthcare stocks have more growth opportunities ahead.

The 7 Best Blue-Chip Stocks in the Dow Jones

By Tezcan Gecgil, InvestorPlace Contributor Apr 2, 2021

These seven blue-chip stocks should appeal to a range of buy-and-hold investors looking for stability, capital growth or passive income.

What Will the Stock Market Do Today? 3 Big Stories to Watch.

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Mar 2, 2021

What will the stock market do today? Investors will focus on Warren's wealth tax, EV stocks and Covid-19 hopes. Here's what to know.

PAND Stock: Why Pandion Therapeutics Shares Have Skyrocketed Today

By William White, InvestorPlace Writer Feb 25, 2021

Pandion Therapeutics (PAND) stock is soaring higher on Thursday after announcing that Merck (MRK) plans to acquire the biotechnology company.

3 Under-the-Radar Biotech Stocks to Buy After Dull Earnings Reactions

By Nicolas Chahine, InvestorPlace Contributor Feb 8, 2021

Investors are enamored with high profile stocks and ignoring ones that are solid investments. Here are three biotech stocks to consider.

7 Pharmaceutical Stocks With Compelling Pipelines

By Chris Lau, InvestorPlace Contributor Feb 2, 2021

Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.

The 7 Best Healthcare Stocks to Buy for 2021

By Tom Taulli, InvestorPlace Contributor Jan 20, 2021

Politics is a wildcard that can negatively impact healthcare stocks. But there are still many top companies with great prospects to consider.

6 Cannabis Stocks to Buy as the U.S. Softens Its Stance

By Lou Carlozo, InvestorPlace Contributor Dec 31, 2020

These 6 cannabis stocks show promise in the medical and recreational ends of the burgeoning marijuana sector, set to grow even more in 2021.

5 Rational Biotech Stocks to Buy

By Neil George Dec 22, 2020

These biotech stocks allow you to profit off the innovations that are giving us longer, healthier lives through the companies that make them.

The 7 Worst Dow Jones Stocks of 2020

By Tom Taulli, InvestorPlace Contributor Dec 22, 2020

The Dow Jones has gained about 5.5% this year, but not everything was so positive. These were the worst stocks in the Dow for 2020.

9 Best Stocks to Buy for the Santa Claus Rally

By Josh Enomoto, InvestorPlace Contributor Dec 4, 2020

With 2020 coming to a close, everyone’s talking about the best stocks to buy under the context of the Santa Claus rally. But just how effective is this methodology?

85 Million & Climbing: Why Pets = Profits for These 6 Companies

By Neil George Dec 3, 2020

More households own pets than have children, and they'll pay to keep their furry friends happy. Here are 6 big pet stocks.

Merck and Biotech’s Swashbuckling Era

By Dana Blankenhorn, InvestorPlace Contributor Nov 25, 2020

MRK stock has entered a new swashbuckling era, searching for new profit gushers like Keytruda, the company's anti-cancer drug.

9 Outbreak-Fueled Stocks to Buy This Week

By Josh Enomoto, InvestorPlace Contributor Nov 11, 2020

While coronavirus numbers start to subside again, many investors are in a pandemic mentality, making these the stocks to buy this week.

5 Industries Biden Would Destroy as President

By Thomas Niel, InvestorPlace Contributor Nov 2, 2020

If Joe Biden wins on Election Day, election stocks in these five industries could hit bad times: Coal, Cruise Lines, Oil and Gas, Pharmaceuticals, Ride Sharing. Tread carefully as voters head to the polls.

Merck & Co (MRK)

The Coronavirus Pill Makes Merck a Solid Buy

Motivation Really Matters When It Comes to Organon

Hold Merck for Its Solid Dividend and Covid-19 Treatment Prospects

7 Dividend Stocks Offering Juicy Yields and Short-Squeeze Potential

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Merck & Co (MRK)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRK Stock Predictions, Articles, and Merck & Co News

Subscriber Sign in